Pharmacologic treatments for covid-19 patients
Aprepitant+Dexamethasone vs Dexamethasone
This comparison will not be updated. Last search date 28 Feb, 2022.
Hospitalized patients
Forest plots
(last update: 2021-06-18)
To access all information :
- click here for Hospitalized patients
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=51
Back to your research
| Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
|---|---|---|---|---|---|---|---|---|
| Treatment 1 | Treatment 2 | |||||||
| NCT04468646 Mehboob R, medRxiv, 2020 Full text Commentary |
No specific funding |
Aprepitant+Dexamethasone |
Dexamethasone |
RCT | Patients with confirmed COVID-19 (mild-critical) admitted to a single center in Pakistan | N=41 |
Some concerns Details |
|